Company number 08473331
Status Active
Incorporation Date 4 April 2013
Company Type Private Limited Company
Address BABRAHAM HALL, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, UNITED KINGDOM, CB22 3AT
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc
Since the company registration eighteen events have happened. The last three records are Confirmation statement made on 4 April 2017 with updates; Total exemption small company accounts made up to 30 April 2016; Director's details changed for Dr Emily Ann Scraggs on 17 November 2016. The most likely internet sites of TALISMAN THERAPEUTICS LIMITED are www.talismantherapeutics.co.uk, and www.talisman-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is twelve years and eight months. The distance to to Shelford (Cambs) Rail Station is 3 miles; to Cambridge Rail Station is 5.2 miles; to Audley End Rail Station is 8.9 miles; to Waterbeach Rail Station is 9 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Talisman Therapeutics Limited is a Private Limited Company.
The company registration number is 08473331. Talisman Therapeutics Limited has been working since 04 April 2013.
The present status of the company is Active. The registered address of Talisman Therapeutics Limited is Babraham Hall Babraham Research Campus Cambridge United Kingdom Cb22 3at. . LIVESEY, Frederick John, Dr is a Director of the company. SCRAGGS, Emily Anne, Dr is a Director of the company. TREHERNE, Jonathan Mark, Dr is a Director of the company. Director SHAH, Sunil Rajen has been resigned. The company operates in "Research and experimental development on biotechnology".
Current Directors
Resigned Directors
Director
SHAH, Sunil Rajen
Resigned: 20 September 2016
Appointed Date: 05 April 2014
52 years old
Persons With Significant Control
Dr Frederick John Livesey
Notified on: 6 April 2016
56 years old
Nature of control: Ownership of shares – More than 50% but less than 75%
TALISMAN THERAPEUTICS LIMITED Events
04 Apr 2017
Confirmation statement made on 4 April 2017 with updates
06 Feb 2017
Total exemption small company accounts made up to 30 April 2016
18 Nov 2016
Director's details changed for Dr Emily Ann Scraggs on 17 November 2016
20 Sep 2016
Termination of appointment of Sunil Rajen Shah as a director on 20 September 2016
14 Apr 2016
Annual return made up to 4 April 2016 with full list of shareholders
Statement of capital on 2016-04-14
...
... and 8 more events
04 Jun 2014
Sub-division of shares on 5 April 2014
04 Jun 2014
Resolutions
-
RES01 ‐
Resolution of Memorandum and/or Articles of Association
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES10 ‐
Resolution of allotment of securities
02 Apr 2014
Appointment of Emily Ann Scraggs as a director
02 Apr 2014
Appointment of Emily Ann Scraggs as a director
04 Apr 2013
Incorporation
-
MODEL ARTICLES ‐
Model articles adopted